SCHEMBL29945173

SCHEMBL29945173

COc1ccc(N2CCN(c3ccc(NC(=O)Oc4ccccc4)cc3F)CC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.60
NPSR1 Q6W5P4 2/20 0.60
MAPT P10636 9/20 0.58
KMT2A Q03164 9/20 0.58
ALDH1A1 P00352 8/20 0.58
USP2 O75604 2/20 0.58
KDM4E B2RXH2 2/20 0.58
MEN1 O00255 8/20 0.56
LMNA P02545 1/20 0.53
POLB P06746 1/20 0.53
CYP2C19 P33261 2/20 0.53
CYP2C9 P11712 1/20 0.53
PKM P14618 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.52
HTT P42858 1/20 0.52
HPGD P15428 3/20 0.52
HSD17B10 Q99714 3/20 0.52
RXFP1 Q9HBX9 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
TSHR P16473 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15928522 1.00 GAA (0.60) GAANPSR1MAPTKMT2AALDH1A1
SCHEMBL15927828 0.91 MAPT (0.62) GAANPSR1MAPTKMT2AALDH1A1
SCHEMBL14764159 0.87 LMNA (0.59) NPSR1MAPTKMT2AALDH1A1USP2
SCHEMBL2543995 0.87 GAA (0.79) GAANPSR1MAPTKMT2AALDH1A1
SCHEMBL13263349 0.84 NPC1 (0.62) GAANPSR1MAPTKMT2AALDH1A1
SCHEMBL11145831 0.83 ALDH1A1 (0.76) GAANPSR1MAPTKMT2AALDH1A1
SCHEMBL14764216 0.82 KMT2A (0.74) NPSR1MAPTKMT2AALDH1A1USP2
SCHEMBL29945184 0.82 KMT2A (0.74) NPSR1MAPTKMT2AALDH1A1USP2
SCHEMBL12983338 0.78 MAPT (0.48) GAANPSR1MAPTKMT2AALDH1A1
SCHEMBL9776029 0.78 GAA (0.61) GAANPSR1MAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12545666-B2 Itraconazole analogs and use thereof THE JOHNS HOPKINS UNIVERSITY (US) 2026-02-10 US disclosed
US-20220363672-A1 ITRACONAZOLE ANALOGS AND USE THEREOF THE JOHNS HOPKINS UNIVERSITY 2022-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363672-A1 ITRACONAZOLE ANALOGS AND USE THEREOF SHH, GLI1, KDR GAA 1408/4885NPSR1 2960/4885MAPT 3556/4885
US-12545666-B2 Itraconazole analogs and use thereof SHH, SMO, GLI1 GAA 4299/4885NPSR1 1439/4885MAPT 2130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.